Company: CAG
Filing Date: 2025-08-06
Form Type: DEF 14A
Source: 0000023217-25-000054
Chunk: 22

Company: CONAGRA BRANDS INC.
Filing Date: 2025-08-06
Form: DEF 14A
Chunk 22
---
 and regulatory updates from legal counsel |

| ● | Reviewing reports from management and discussing policies, practices, and procedures with respect to significant and emerging enterprise-wide risks facing the Company |

| ● | Reviewing significant Company policies and programs designed to mitigate significant risks to the Company |

| ● | Holding regular executive sessions with external advisors, such as our independent auditors and compensation consultant, and |

| ● | Supporting a strong internal audit function with our Internal Audit function, Chief Financial Officer, and Controller |

Board Self-Evaluation Our Board is committed to a rigorous self-evaluation process. Each of the Board, the Audit / Finance Committee, the HR Committee, and the Nominating and Corporate Governance Committee conducts a self-evaluation of its performance on an annual basis. In addition, individual director evaluations are conducted annually. Our evaluation process is designed to elicit feedback on the processes, structure, composition, and effectiveness of the Board and includes individual discussions to encourage open dialogues, including feedback by those members of senior leadership who interact with the Board and committees. The evaluation process has increased Board effectiveness and provides our Nominating and Corporate Governance Committee with valuable insights that inform its director nomination process. Director Attendance Our Board holds 5 regularly scheduled meetings each year. At each regular Board meeting, time is set aside for the independent directors to meet without management present. Additional executive sessions are held as needed. Each of the Board’s Audit / Finance Committee, HR Committee, and Nominating and Corporate Governance Committee hold 4 to 5 regularly scheduled meetings each year with our Audit / Finance Committee meeting more frequently, as needed, to review and approve quarterly and annual financial statements and earnings releases.

| In addition to these regularly scheduled meetings, our Board and its committees meet as needed at special meetings, such that our Board met a total of 8 times during fiscal 2025. Each current director attended at least 75% of the aggregate of all fiscal 2025 meetings of the Board and each committee on which he or she served (during the period in which he or she served). In fiscal 2025, the Board and committees of the Board held a total of 25 meetings. Together, the current directors attended at least 98% of the combined total meetings of the Board and the committees on which they were members in fiscal 2025. |     | DIRECTOR                 
 ATTENDANCEAVERAGE 98% AT 
 COMBINED BOARD           
 AND COMMITTEE            
 MEETINGS                 |

Directors are expected to attend the Company’s annual meetings